Landmark Cancer Clinical Trials and Real-World Patient Populations: Examining Race and Age Reporting

Background: Concern exists that the clinical trial populations differ from respective cancer populations in terms of their age distribution affecting the generalizability of the results, especially in underrepresented minorities. We hypothesized that the clinical trials that do not report race are l...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Thejus Jayakrishnan, Sonikpreet Aulakh, Mizba Baksh, Kianna Nguyen, Meghna Ailawadhi, Ayesha Samreen, Ricardo Parrondo, Taimur Sher, Vivek Roy, Rami Manochakian, Aneel Paulus, Asher Chanan-Khan, Sikander Ailawadhi
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	clinical trials cancer disparity age race Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/4902baa6ea224b818c6a583586ed5b2c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

Landmark Cancer Clinical Trials and Real-World Patient Populations: Examining Race and Age Reporting

Ejemplares similares